RALLIS CHRIS A
SEC Form 4 insider trading activity
RALLIS CHRIS A has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: May 12, 2026.
On the most recent filing, RALLIS CHRIS A is listed as Director at FENNEC PHARMACEUTICALS INC. Inside the rolling window, RALLIS CHRIS A reported no open-market purchases and 1 open-market sale totaling $59K in FENC.
Companies traded
Other insiders at FENC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$59K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 10, 2025 | FENC | Sale | $16K |
Frequently asked questions
How many SEC Form 4 filings has RALLIS CHRIS A made?
RALLIS CHRIS A has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does RALLIS CHRIS A trade?
RALLIS CHRIS A has filed SEC Form 4 disclosures for 1 company, including FENC.
When was RALLIS CHRIS A's most recent SEC Form 4 filing?
RALLIS CHRIS A's most recent SEC Form 4 filing on Tracefour is dated May 12, 2026.
What is RALLIS CHRIS A's total buy and sell value in the current window?
Inside the rolling retention window, RALLIS CHRIS A bought $0 and sold $59K based on SEC Form 4 filings.
What was RALLIS CHRIS A's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,346 FENC shares on 2026-05-11, worth $59K, per SEC Form 4 filings.